BioCentury
ARTICLE | Company News

Activaero, Chiesi deal

September 16, 2013 7:00 AM UTC

The companies partnered to evaluate a drug-device combination product using Activaero's Flow and Volume Controlled Inhalation Technology (FAVORITE) and Chiesi's Bethkis inhaled tobramycin solution to...